Marquette Asset Management’s Avidity Biosciences RNAM Stock Holding History

Marquette Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$1.01K	–	892
2025 Q4	$1.01K	Buy	+14	New	+$904	﹤0.01%	564

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Marquette Asset Management's RNAM Position: Q1 2026 in Review

Marquette Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 14 shares — an estimated $1.01K sold.

Marquette Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.01K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Marquette Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Marquette Asset Management sold 14 Avidity Biosciences shares in Q1 2026, an estimated $1.01K.
Marquette Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Marquette Asset Management's Avidity Biosciences position peaked at $1.01K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Marquette Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.